1932

Abstract

This review summarizes the theoretical and empirical literature on the importance of linkages between universities and industries in the development of commercial applications of biotechnology. These linkages range from formal agreements, such as patent licenses and research alliances, to informal collaborations, such as joint research, copublication, and consulting. Because biotechnology involves a new research method, the tacit knowledge embedded in it became critical to its commercialization. Specifically, it requires the direct involvement of star scientists who have this tacit knowledge and are well remunerated for it. This process is facilitated by the passage of the Bayh–Dole Act, which allows universities to retain ownership of crucial patents and provides incentives to the star scientists to cooperate in development and commercialization. Over time, a complex web of collaborations and alliances has evolved in therapeutic, diagnostic, and pharmaceutical biotechnology, whereas extensive consolidation has occurred in agricultural biotechnology.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-resource-100815-095400
2016-10-05
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/resource/8/1/annurev-resource-100815-095400.html?itemId=/content/journals/10.1146/annurev-resource-100815-095400&mimeType=html&fmt=ahah

Literature Cited

  1. Aghion P, Tirole J. 1994. The management of innovation. Q. J. Econ. 109:1185–209 [Google Scholar]
  2. Aharonson B, Baum J, Feldman M. 2007. Desperately seeking spillovers? Increasing returns, industrial organization and the location of new entrants in geographic and technological space. Ind. Corp. Change 16:89–130 [Google Scholar]
  3. Argyres N, Liebeskind J. 1998. Privatizing the intellectual commons: universities and the commercialization of biotechnology. . J. Econ. Behav. Organ. 35:4427–54 [Google Scholar]
  4. Arora A, Gambardella A. 1990. Complementarity and external linkages: the strategies of the large firms in biotechnology. J. Ind. Econ. 38:361–79 [Google Scholar]
  5. Arora A, Gambardella A. 1994. Evaluating technological information and utilizing it: scientific knowledge, technological capability, and external linkages in biotechnology. J. Econ. Behav. Organ. 24:91–114 [Google Scholar]
  6. Arrow K. 1962. Economic welfare and the allocation of resources for inventions. The Rate and Direction of Inventive Activity R Nelson 165–80 Princeton, NJ: Princeton Univ. Press [Google Scholar]
  7. Audretsch DB, Stephan PE. 1999. Knowledge spillovers in biotechnology: sources and incentives. J. Evol. Econ. 9:97–107 [Google Scholar]
  8. Banal-Estañol A, Macho-Stadler I, Pérez-Castrillo D. 2013. Endogeneous matching in university-industry collaboration: theory and empirical evidence from the UK Work. Pap., Dep. Econ. Bus., Univ Pompeu Fabra, Barcelona, Spain:
  9. Barham B, Foltz J, Kim K. 2002. Trends in university ag-biotech patent production. Rev. Agric. Econ. 24:294–308 [Google Scholar]
  10. Barrows G, Sexton S, Zilberman D. 2014. Agricultural biotechnology: the promise and prospects of genetically modified crops. J. Econ. Perspect. 28:99–120 [Google Scholar]
  11. Beath J, Owen R, Poyago-Theotoky J, Ulph D. 2003. Optimal incentives for income-generation in universities: the rule of thumb for the Compton tax. Int. J. Ind. Organ. 21:1301–22 [Google Scholar]
  12. Beaudry C, Kananian R. 2013. Follow the (industry) money: the impact of science networks and industry-to-university contracts on academic patenting in nanotechnology and biotechnology. Ind. Innov. 20:241–60 [Google Scholar]
  13. Beggs AW. 1992. The licensing of patents under asymmetric information. Int. J. Ind. Organ. 10:171–91 [Google Scholar]
  14. Blume-Kohout M, Kumar K, Lau C, Sood N. 2015. The effect of federal research funding on formation of university-firm biopharmaceutical alliances. J. Technol. Transf. 40:5859–76 [Google Scholar]
  15. Chukumba CO, Jensen RA. 2005. University invention, entrepreneurship, and start-ups NBER Work. Pap . 11475
  16. Cohen S, Chang A, Boyer H, Helling R. 1973. Construction of biologically functional bacterial plasmids in vitro. PNAS 70:3240–44 [Google Scholar]
  17. Cohen WM, Levinthal DA. 1990. Absorptive capacity: a new perspective on learning and innovation. Admin. Sci. Q. 35:128–52 [Google Scholar]
  18. D'Amore R, Iorio R, Labory S, Stawinoga A. 2013. Research collaboration networks in biotechnology: exploring the trade-off between institutional and geographic distances. Ind. Innov. 20:261–76 [Google Scholar]
  19. Dechenaux E, Thursby M, Thursby J. 2009. Shirking, sharing risk and shelving: the role of university license contracts. Int. J. Ind. Organ. 27:80–91 [Google Scholar]
  20. Diez MCF, Gil-Delgado MRC. 2003. Regulatory factors affecting the agri-food biotechnology sector in the European Union. Work. Pap. 28597, Dep. Agric. Resour. Econ Univ. Md., College Park, MD:
  21. Feldman MP, Colaianni A, Liu CK. 2007. Lessons from the commercialization of the Cohen-Boyer patents: the Stanford University licensing program. ipHandbook Best Practices Blog chapter 17.22 . http://www.iphandbook.org/handbook/ch17/p22/
  22. Foltz J, Barham B, Kim K. 2002. Universities and agricultural biotechnology patent production. Agribusiness 16:82–95 [Google Scholar]
  23. Foltz J, Kim K, Barham B. 2003. A dynamic analysis of university agricultural biotechnology patent production. Am. J. Agric. Econ. 85:187–97 [Google Scholar]
  24. Gallini NT, Wright BD. 1990. Technology transfer under asymmetric information. Rand J. Econ. 21:147–60 [Google Scholar]
  25. Gittelman M. 2005. What makes research socially useful? Complementarities between in-house research and firm-university collaboration in biotechnology. Rev. Econ. Ind. 2:57–73 [Google Scholar]
  26. Glenna L, Welsh R, Ervin D, Lacy W, Biscotti D. 2011. Commercial science, scientists' values, and university biotechnology research agendas. Res. Policy 40:957–68 [Google Scholar]
  27. Graff G, Rausser G, Small A. 2003. Agricultural biotechnology's complementary intellectual assets. Rev. Econ. Stat. 85:349–63 [Google Scholar]
  28. Guerzoni M, Taylor A, Audretsch D, Desai S. 2014. A new industry creation and originality: insight from the funding sources of university patents. Res. Policy 43:1697–706 [Google Scholar]
  29. Heisey P, King J, Day Rubenstein K. 2005. Patterns of public-sector and private-sector patenting in agricultural biotechnology. AgBioForum 8:73–82 [Google Scholar]
  30. Hellmann T. 2007. The role of patents for bridging the science to market gap. J. Econ. Behav. Organ. 63:624–47 [Google Scholar]
  31. Hoppe HC, Ozdenoren E. 2005. Intermediation in innovation. Int. J. Ind. Organ. 23:483–503 [Google Scholar]
  32. Jensen R, Thursby M. 2001. Proofs and prototypes for sale: the licensing of university inventions. Am. Econ. Rev. 91:240–59 [Google Scholar]
  33. Jensen RA. 2011. Startup firms from research in U.S. universities. Handbook of Research on Innovation and Entrepreneurship DB Audretsch, O Falck, S Heblich, A Lederer 273–89 Cheltenham, UK: Edward Elgar [Google Scholar]
  34. Jensen RA, Thursby JG, Thursby MC. 2003. Disclosure and licensing of university inventions: ‘the best we can do with the s**t we get to work with. Int. J. Ind. Organ. 21:1271–300 [Google Scholar]
  35. Jensen RA, Thursby JG, Thursby MC. 2010. University-industry spillovers, government funding, and industrial consulting NBER Work. Pap.15732 [Google Scholar]
  36. Jong S. 2008. Academic organizations and new industrial fields: Berkeley and Stanford after the rise of biotechnology. Res. Policy 37:1267–82 [Google Scholar]
  37. Kato M, Odagiri H. 2012. Development of university life-science programs and university–industry joint research in Japan. Res. Policy 41:939–52 [Google Scholar]
  38. Kolympiris C, Kalaitzandonakes N, Miller D. 2014. Public funds and local biotechnology firm creation. Res. Policy 43:121–37 [Google Scholar]
  39. Lehrer M. 2007. Organizing knowledge spillovers when basic and applied research are interdependent: German biotechnology policy in historical perspective. J. Technol. Transf. 32:277–96 [Google Scholar]
  40. Lehrer M, Asakawa K. 2004. Rethinking the public sector: idiosyncrasies of biotechnology commercialization as motors of national R&D reform in Germany and Japan. Res. Policy 33:921–38 [Google Scholar]
  41. Lemarie S, Mangematin V, Torre A. 2001. Is the creation and development of biotech SMEs localised? Conclusions drawn from the French case. Small Bus. Econ. 17:61–76 [Google Scholar]
  42. Liebeskind J, Oliver A, Zucker L, Brewer M. 1995. Social networks, learning, and flexibility: sourcing scientific knowledge in new biotechnology firms NBER Work. Pap 5320
  43. Lim T-A, Veugelers R. 2003. On equity as a payment device in technology licensing with moral hazard Work. Pap., Dep. Manag. Econ. Strategy Innov., Kathol. Univ Leuven, Leuven, Belg.:
  44. Link A, Scott J. 2005. Opening the ivory tower's door: an analysis of the determinants of the formation of U.S. university spin-off companies. Res. Policy 34:1106–12 [Google Scholar]
  45. Lynskey M. 2006. Transformative technology and institutional transformation: coevolution of biotechnology venture firms and the institutional framework in Japan. Res. Policy 35:1389–422 [Google Scholar]
  46. Macho-Stadler I, Martínez-Giralt X, Pérez-Castrillo D. 1996. The role of information in licensing contract design. Res. Policy 25:43–57 [Google Scholar]
  47. Macho-Stadler I, Pérez-Castrillo D. 2010. Incentives in university technology transfers. Int. J. Ind. Organ. 28:362–67 [Google Scholar]
  48. Macho-Stadler I, Pérez-Castrillo D, Veugelers R. 2007. Licensing of university inventions: the role of a technology transfer office. Int. J. Ind. Organ. 25:483–510 [Google Scholar]
  49. Marco A, Rausser G. 2008. The role of patent rights in mergers: consolidation in plant biotechnology. Am. J. Agric. Econ. 90:133–51 [Google Scholar]
  50. Marco A, Rausser G. 2011. Complementarities and spillovers in mergers: an empirical investigation using patent data. Econ. Innov. New Technol. 20:207–31 [Google Scholar]
  51. McKelvey M, Alm H, Riccaboni M. 2003. Does co-location matter for formal knowledge collaboration in the Swedish biotechnology–pharmaceutical sector?. Res. Policy 32:483–501 [Google Scholar]
  52. McMillan GS, Narin F, Deeds D. 2000. An analysis of the critical role of public science in innovation: the case of biotechnology. Res. Policy 29:1–8 [Google Scholar]
  53. Mendel G. 1866. Versuche über Pflanzen-Hybriden [Experiments on plant hybridization]. Verh. Naturforsch. Ver. Brünn. 4:3–47 [Google Scholar]
  54. Niosi J. 2006. Success factors in Canadian academic spin-offs. J. Technol. Transf. 31:451–57 [Google Scholar]
  55. Oehmke J. 2001. Biotechnology R&D races, industry structure, and public and private sector research orientation. AgBioForum 4:105–14 [Google Scholar]
  56. Oliver AL. 2004. Biotechnology entrepreneurial scientists and their collaborations. Res. Policy 33:583–97 [Google Scholar]
  57. Owen-Smith J, Powell WW. 2003. The expanding role of university patenting in the life sciences: assessing the importance of experience and connectivity. Res. Policy 32:1695–711 [Google Scholar]
  58. Owen-Smith J, Powell WW. 2006. Accounting for emergence and novelty in Boston and Bay Area biotechnology. Cluster Genesis: The Emergence of Technology Clusters and Their Implications for Government Policies P Braunerhjelm, M Feldman 61–86 Oxford, UK: Oxford Univ. Press [Google Scholar]
  59. Powell WW, Brantley P. 1992. Competitive cooperation in biotechnology: learning through networks. Networks and Organizations: Structure, Form and Action N Nohria, R Eccles 366–94 Boston, MA: Harvard Bus. Sch. Press [Google Scholar]
  60. Rausser GC, Scotchmer S, Simon LK. 1999. Intellectual property and market structure in agriculture Work. Pap. 880, Dep. Agric. Resour. Econ., Univ. Calif Berkeley, CA:
  61. Rausser G, Simon L, Ameden H. 2000. Public-private alliances in biotechnology: Can they narrow the knowledge gaps between rich and poor?. Food Policy 25:499–513 [Google Scholar]
  62. Rausser G, Small A. 1996. The economic value of patents, licenses, and plant variety protection Work. Pap. 797, Dep. Agric. Resour. Econ., Univ. Calif Berkeley, CA:
  63. Schienstock G, Tulkki P. 2001. The fourth pillar? An assessment of the situation of the Finnish biotechnology. Small Bus. Econ. 17:105–22 [Google Scholar]
  64. Scotchmer S. 2013. Patents in the university: priming the pump and crowding out. J. Ind. Econ. 61:817–44 [Google Scholar]
  65. Shane S. 2002. Selling university technology. Manag. Sci. 48:122–37 [Google Scholar]
  66. Showalter D, Jensen R. 2009. University inventions licensed through start-ups Work. Pap., Dep. Econ., Univ. Notre Dame Notre Dame, IN:
  67. Silveira R, Wright R. 2010. Search and the market for ideas. J. Econ. Theory 45:1550–73 [Google Scholar]
  68. Smith HL, Bagchi-Sen S. 2006. University–industry interactions: the case of the UK biotech industry. Ind. Innov. 13:371–92 [Google Scholar]
  69. Stevens A. 2004. The enactment of Bayh–Dole. J. Technol. Transf. 29:93–99 [Google Scholar]
  70. Stuart T, Ozdemir S, Ding W. 2007. Vertical alliance networks: the case of university–biotechnology–pharmaceutical alliance chains. Res. Policy 36:477–98 [Google Scholar]
  71. Subramanian A, Lim K, Soh P. 2013. When birds of a feather don't flock together: different scientists and the roles they play in biotech R&D alliances. Res. Policy 42:595–612 [Google Scholar]
  72. Thomson J. 2004. The status of plant biotechnology in Africa. AgBioForum 7:9–12 [Google Scholar]
  73. Thursby JG, Jensen R, Thursby MC. 2001. Objectives, characteristics and outcomes of university licensing: a survey of major U.S. universities. J. Technol. Transf. 26:59–72 [Google Scholar]
  74. Thursby J, Thursby M. 2011. University-industry linkages in nanotechnology and biotechnology: evidence on collaborative patterns for new methods of inventing. J. Technol. Transf. 36:605–23 [Google Scholar]
  75. Trippl M, Todtling F. 2008. From the ivory tower to the marketplace: knowledge organizations in the development of biotechnology clusters. J. Reg. Anal. Policy 38:159–75 [Google Scholar]
  76. Xia Y, Buccola S. 2005. University life science programs and agricultural biotechnology. Am. J. Agric. Econ. 87:229–43 [Google Scholar]
  77. Yague-Perales R, Niosi J, March-Chorda I. 2015. Benchmarking biotechnology industries: a comparative perspective. Int. Entrep. Manag. J. 11:19–38 [Google Scholar]
  78. Zhang J. 2009. The performance of university spin-offs: an exploratory analysis using venture capital data. J. Technol. Transf. 34:255–85 [Google Scholar]
  79. Zucker LG, Darby MR. 1996. Star scientists and institutional transformation: patterns of invention and innovation in the formation of the biotechnology industry. PNAS 93:12709–16 [Google Scholar]
  80. Zucker LG, Darby MR. 2001. Capturing technological opportunity via Japan's star scientists: evidence from Japanese firms' biotech patents and products. J. Technol. Transf. 26:37–58 [Google Scholar]
  81. Zucker LG, Darby MR, Armstrong JS. 1998a. Geographically localized knowledge: spillovers or markets?. Econ. Inquiry 36:65–86 [Google Scholar]
  82. Zucker LG, Darby MR, Armstrong JS. 2002. Commercializing knowledge: university science, knowledge capture, and firm performance in biotechnology. Manag. Sci. 48:138–53 [Google Scholar]
  83. Zucker LG, Darby MR, Brewer MB. 1998b. Intellectual human capital and the birth of U.S. biotechnology enterprises. Am. Econ. Rev. 88:290–306 [Google Scholar]
/content/journals/10.1146/annurev-resource-100815-095400
Loading
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error